T1	chemical 56 60	lead
T2	disease_or_phenotypic_feature 74 83	infection
T3	chemical 236 246	biomarkers
T4	disease_or_phenotypic_feature 296 299	CMD
T5	chemical 403 408	HbA1c
T6	disease_or_phenotypic_feature 472 484	osteoporosis
T7	chemical 577 581	mRNA
T8	disease_or_phenotypic_feature 609 615	glioma
T9	chemical 718 729	L-carnitine
T10	disease_or_phenotypic_feature 768 773	blood
T11	chemical 784 793	bilirubin
T12	chemical 856 863	Retinal
T13	chemical 899 906	Retinal
T14	disease_or_phenotypic_feature 899 921	Retinal Vein Occlusion
T15	chemical 996 1009	enzyme-linked
T16	disease_or_phenotypic_feature 1064 1070	HS-RLS
T17	chemical 1196 1204	fentanyl
T18	chemical 1214 1224	metabolite
T19	chemical 1225 1236	norfentanyl
T20	chemical 1296 1305	celecoxib
T21	chemical 1307 1316	estazolam
T22	chemical 1318 1330	promethazine
T23	chemical 1336 1346	sertraline
T24	disease_or_phenotypic_feature 1363 1368	blood
T25	chemical 1460 1470	Lenvatinib
T26	chemical 1474 1482	molecule
T27	disease_or_phenotypic_feature 1562 1573	anti-cancer
T28	chemical 1606 1614	chemical
T29	disease_or_phenotypic_feature 1772 1777	(ECD)
T30	disease_or_phenotypic_feature 1810 1818	SDS-PAGE
T31	chemical 1839 1851	polypeptides
T32	chemical 2004 2008	base
T33	disease_or_phenotypic_feature 2031 2040	influenza
T34	disease_or_phenotypic_feature 2160 2167	abscess
T35	chemical 2285 2296	clindamycin
T36	disease_or_phenotypic_feature 2355 2366	hypotension
T37	chemical 2391 2396	group
T38	chemical 2527 2536	IGF1R/IRS
T39	disease_or_phenotypic_feature 2564 2592	acute lymphoblastic leukemia
T40	chemical 2642 2652	inhibitors
T41	chemical 2660 2669	IGF1R-IRS
T42	chemical 2673 2682	inhibitor
T43	chemical 2697 2705	IGF1R/IR
T44	chemical 2706 2715	inhibitor
T45	chemical 2739 2746	protein
T46	chemical 2834 2841	citrate
T47	chemical 2868 2878	nucleotide
T48	disease_or_phenotypic_feature 2925 2931	common
T49	disease_or_phenotypic_feature 3006 3009	TGA
T50	disease_or_phenotypic_feature 3022 3026	gave
T51	chemical 3097 3106	oxidation
T52	disease_or_phenotypic_feature 3136 3145	Intrinsic
T53	chemical 3186 3193	histone
T54	corrected_disease_or_phenotypic_feature 3287 3318	acute severe ulcerative colitis
T55	disease_or_phenotypic_feature 3300 3318	ulcerative colitis
T56	disease_or_phenotypic_feature 3366 3388	system-PLGA-KPV/MMT/CS
T57	chemical 3415 3428	nanoparticles
T58	chemical 3441 3455	cyclosporine A
T59	missed_chemical 3457 3460	CyA
T60	chemical 3503 3520	mineral-medicinal
T61	chemical 3521 3526	water
T62	disease_or_phenotypic_feature 3544 3556	fibromyalgia
R1	treats Arg1:T59 Arg2:T54
R2	treats Arg1:T58 Arg2:T54
T63	corrected_disease_or_phenotypic_feature 1567 1573	cancer
R3	treats Arg1:T25 Arg2:T63	
R4	treats Arg1:T26 Arg2:T63	
T64	missed_disease_or_phenotypic_feature 3320 3324	ASUC
R5	treats Arg1:T58 Arg2:T64	
R6	treats Arg1:T59 Arg2:T64	
T65	missed_disease_or_phenotypic_feature 829 831	HE
R7	treats Arg1:T9 Arg2:T65	
R8	treats Arg1:T35 Arg2:T34	
T66	missed_chemical 2653 2658	NT157
T67	corrected_chemical 2661 2682	GF1R-IRS1/2 inhibitor
T68	missed_chemical 2688 2695	OSI-906
T69	corrected_chemical 2697 2715	IGF1R/IR inhibitor
R9	treats Arg1:T66 Arg2:T39	
R10	treats Arg1:T67 Arg2:T39	
R11	treats Arg1:T68 Arg2:T39	
R12	treats Arg1:T69 Arg2:T39	
T70	missed_disease_or_phenotypic_feature 2594 2597	ALL
R13	treats Arg1:T69 Arg2:T70	
R14	treats Arg1:T68 Arg2:T70	
R15	treats Arg1:T66 Arg2:T70	
R16	treats Arg1:T67 Arg2:T70	
T71	corrected_chemical 3373 3428	PLGA-KPV/MMT/CS multifunctional medicinal nanoparticles
R17	treats Arg1:T71 Arg2:T64	
R18	treats Arg1:T71 Arg2:T54	
T72	corrected_chemical 3503 3526	mineral-medicinal water
R19	treats Arg1:T72 Arg2:T62	
T73	corrected_chemical 2626 2652	pharmacological inhibitors
R20	treats Arg1:T73 Arg2:T70	
R21	treats Arg1:T73 Arg2:T39	
